Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.18 - $0.57 $0 - $0
-1 Reduced 50.0%
1 $0
Q1 2022

May 16, 2022

BUY
$12.1 - $20.6 $12 - $20
1 Added 100.0%
2 $0
Q4 2021

Feb 08, 2022

SELL
$14.4 - $30.4 $170,812 - $360,604
-11,862 Reduced 99.99%
1 $0
Q3 2021

Nov 15, 2021

BUY
$30.6 - $58.1 $363,007 - $689,240
11,863 New
11,863 $36,000

Others Institutions Holding PHGE

About BiomX Inc.


  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $21.9M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.